IVERIC bio (ISEE) News Today → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free ISEE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 10, 2024 | investing.comAstellas Pharma Inc (ALPMY)December 15, 2023 | msn.comApellis falls on potential EU snub for eye therapy (update)December 7, 2023 | seekingalpha.comAkoya Biosciences: 2024 Could Be The Year To Own Their StockDecember 1, 2023 | msn.comApellis adds safety warning to eye therapyAugust 14, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Given Consensus Rating of "Hold" by AnalystsShares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Free Report) have been given an average rating of "Hold" by the ten analysts that are currently covering the company, MarketBeat.com reports. Ten equities research analysts have rated the stock with a hold recommendation. The average 12-month target prAugust 7, 2023 | marketbeat.comAmalgamated Bank Reduces Stock Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)Amalgamated Bank cut its position in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Free Report) by 14.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 19,205 shares of the company's stock after sJuly 20, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Given Consensus Rating of "Hold" by BrokeragesIVERIC bio, Inc. (NASDAQ:ISEE - Get Free Report) has received an average recommendation of "Hold" from the ten research firms that are currently covering the company, MarketBeat reports. Ten investment analysts have rated the stock with a hold rating. The average 1-year target price among analystsJuly 17, 2023 | marketbeat.comState of New Jersey Common Pension Fund D Boosts Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)State of New Jersey Common Pension Fund D raised its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Free Report) by 12.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 120,410 shares of the company's sJuly 11, 2023 | finance.yahoo.comAstellas Completes Acquisition of Iveric BioJuly 11, 2023 | marketbeat.comTrading was temporarily halted for "ISEE" at 07:07 PM with a stated reason of "News pending."July 9, 2023 | marketbeat.comDnB Asset Management AS Takes $335,000 Position in IVERIC bio, Inc. (NASDAQ:ISEE)DnB Asset Management AS bought a new position in IVERIC bio, Inc. (NASDAQ:ISEE - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 13,770 shares of the company's stock, valued at approximately $July 5, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Acquired by Hennion & Walsh Asset Management Inc.Hennion & Walsh Asset Management Inc. boosted its position in IVERIC bio, Inc. (NASDAQ:ISEE - Free Report) by 4.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 78,946 shares of the company's stock aftJune 30, 2023 | markets.businessinsider.comB.Riley Financial Sticks to Its Hold Rating for IVERIC bio (ISEE)June 27, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Acquired by Chartwell Investment Partners LLCChartwell Investment Partners LLC increased its position in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 39.1% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 53,720 shares of the company's stock after purchasing an additional 15,095 sJune 25, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Receives Average Rating of "Hold" from AnalystsIVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) has been assigned an average recommendation of "Hold" from the ten analysts that are currently covering the stock, Marketbeat.com reports. Ten investment analysts have rated the stock with a hold recommendation. The average 12-month target price among anJune 24, 2023 | marketbeat.comVoya Investment Management LLC Purchases 171,434 Shares of IVERIC bio, Inc. (NASDAQ:ISEE)Voya Investment Management LLC lifted its position in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 84.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 373,531 shares of the company's stock after acquiring an additional 171,434 shares dJune 20, 2023 | marketbeat.comIVERIC bio (NASDAQ:ISEE) Now Covered by Analysts at StockNews.comStockNews.com initiated coverage on shares of IVERIC bio in a research note on Tuesday. They issued a "sell" rating for the company.June 16, 2023 | marketbeat.comNeo Ivy Capital Management Purchases Shares of 17,910 IVERIC bio, Inc. (NASDAQ:ISEE)Neo Ivy Capital Management purchased a new stake in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 17,910 shares of the company's stock, valued at approximJune 14, 2023 | marketbeat.comEversept Partners LP Purchases New Shares in IVERIC bio, Inc. (NASDAQ:ISEE)Eversept Partners LP purchased a new stake in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 350,747 shares of the company's stock, valued at approJune 9, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Sold by GSA Capital Partners LLPGSA Capital Partners LLP decreased its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 78.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,363 shares of the company's stock after selling 64,985 shaJune 8, 2023 | marketbeat.comAmerican International Group Inc. Buys 7,390 Shares of IVERIC bio, Inc. (NASDAQ:ISEE)American International Group Inc. increased its position in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 13.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,652 shares of the compaJune 5, 2023 | marketbeat.comPrincipal Financial Group Inc. Grows Stock Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)Principal Financial Group Inc. grew its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 10.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,705 shares of the company's stock after buyiJune 2, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Sold by Moore Capital Management LPMoore Capital Management LP lowered its holdings in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 12.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 210,000 shares of the company's stock after sellMay 31, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Given Average Rating of "Hold" by BrokeragesIVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) has earned an average recommendation of "Hold" from the twelve analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating toMay 30, 2023 | seekingalpha.comIveric bio, Still A 5+% OpportunityMay 30, 2023 | finance.yahoo.comAnnexon (ANNX) Stock Down More Than 50% Last Week: Here's WhyMay 29, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Sold by Artal Group S.A.Artal Group S.A. cut its holdings in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 20.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,000,000 shares of the company's stoMay 23, 2023 | seekingalpha.comBayer, Amgen looked at Iveric before agreeing to Astellas sale - reportMay 22, 2023 | marketbeat.comCitigroup Inc. Reduces Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)Citigroup Inc. trimmed its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 64.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 179,348 shares of the company's stockMay 18, 2023 | marketbeat.comTimesSquare Capital Management LLC Makes New Investment in IVERIC bio, Inc. (NASDAQ:ISEE)TimesSquare Capital Management LLC bought a new position in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,011,640 shares of the company's stock, vMay 17, 2023 | msn.comUnusual Call Option Trade in IVERIC bio (ISEE) Worth $1,780.50KMay 17, 2023 | marketbeat.comArizona State Retirement System Boosts Stock Position in IVERIC bio, Inc. (NASDAQ:ISEE)Arizona State Retirement System boosted its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 45.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 32,123 shares of the company's stock aftMay 15, 2023 | marketbeat.comQ2 2023 EPS Estimates for IVERIC bio, Inc. Reduced by Analyst (NASDAQ:ISEE)IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) - Investment analysts at Wedbush lowered their Q2 2023 earnings estimates for shares of IVERIC bio in a research report issued on Wednesday, May 10th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.5May 11, 2023 | fool.comIVERIC Bio (NASDAQ: ISEE)May 9, 2023 | msn.comTD Cowen Downgrades IVERIC bio (ISEE)May 8, 2023 | marketbeat.comSkandinaviska Enskilda Banken AB publ Reduces Stock Position in IVERIC bio, Inc. (NASDAQ:ISEE)Skandinaviska Enskilda Banken AB publ lessened its holdings in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 0.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 790,802 shares of the company's stock afteMay 2, 2023 | marketwatch.comSHAREHOLDER ALERT: Weiss Law Investigates IVERIC bio, Inc.May 2, 2023 | benzinga.comMoore Kuehn Encourages ISEE, MDWT, CBOF, and SGEN Investors to Contact Law FirmMay 2, 2023 | marketbeat.comSwiss National Bank Buys 82,000 Shares of IVERIC bio, Inc. (NASDAQ:ISEE)Swiss National Bank lifted its stake in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 42.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 275,200 shares of the company's stock after buying an additional 82,000 shares during the quaMay 1, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating IVERIC bio, Inc. BuyoutMay 1, 2023 | benzinga.comCheck Out What Whales Are Doing With ISEEMay 1, 2023 | finance.yahoo.comAstellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'May 1, 2023 | finance.yahoo.comBiotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas PharmaMay 1, 2023 | finance.yahoo.comThese Stocks Are Moving the Most Today: First Republic, JPMorgan, Iveric Bio, SoFi, ON Semi, and MoreMay 1, 2023 | finance.yahoo.comFirst Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top StoriesMay 1, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether IVERIC bio, Inc. has obtained a Fair Price in its transaction with AstellasMay 1, 2023 | technews.tmcnet.comISEE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Iveric bio, Inc. Is Fair to ShareholdersMay 1, 2023 | marketwatch.comIveric Bio Shares Rise Premarket on Takeover by Astellas >ISEEMay 1, 2023 | msn.comIveric Bio Stock Surges. It's Being Bought by Astellas for $5.9 Billion.May 1, 2023 | finance.yahoo.comJapan’s Astellas to buy US biotech group Iveric Bio for $5.9bn Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ISEE and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. ISEE Media Mentions By Week ISEE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ISEE News Sentiment▼0.450.55▲Average Medical News Sentiment ISEE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ISEE Articles This Week▼00▲ISEE Articles Average Week Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ISEE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Glaukos News Today ImmunityBio News Today Apellis Pharmaceuticals News Today Option Care Health News Today Lantheus News Today Organon & Co. News Today Bausch + Lomb News Today Halozyme Therapeutics News Today BridgeBio Pharma News Today DENTSPLY SIRONA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ISEE) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IVERIC bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
